Insulin resistance, obesity and breast cancer risk

Maturitas

Volumn 60, Issue 1, 2008, Pages 19-30

  Pichard, C ^a   Plu Bureau, G ^a   Neves e Castro, M ^b   Gompel, A ^a  

^a HÔTEL DIEU   (France)

^b Clinica de Feminologia Holistica   (Portugal)

Author keywords

Adipocytokines; BMI; Estradiol; IGF I; Testosterone; Waist circumference; Waist to hip ratio

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANDROGEN; ANDROSTENEDIONE; BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN; LEPTIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ANOVULATION; AROMATIZATION; BODY FAT DISTRIBUTION; BODY MASS; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CELL HETEROGENEITY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; DISEASE MARKER; HEIGHT; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; MENSTRUAL CYCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTMENOPAUSE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; WEIGHT GAIN;

ADIPOKINES; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN RESISTANCE; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 45849102031     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.03.002     Document Type: Review

References (55)

1. Lahmann P.H., Hoffmann K., Allen N., et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 111 5 (2004) 762-771
2. Michels K.B., Terry K.L., and Willett W.C. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 166 21 (2006) 2395-2402
3. Van den Brandt P.A., Spiegelman D., Yaun S.S., et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 152 6 (2000) 514-527
4. Shu X.O., Jin F., Dai Q., et al. Association of body size and fat distribution with risk of breast cancer among Chinese women. Int J Cancer 94 3 (2001) 449-455
5. Baer H.J., Colditz G.A., Rosner B., et al. Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 7 3 (2005) R314-R325
6. Baer H.J., Rich-Edwards J.W., Colditz G.A., et al. Adult height, age at attained height, and incidence of breast cancer in premenopausal women. Int J Cancer 119 9 (2006) 2231-2235
7. Weiderpass E., Braaten T., Magnusson C., et al. Prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13 7 (2004) 1121-1127
8. Garland M., Hunter D.J., Colditz G.A., et al. Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 147 7 (1998) 636-643
9. Rich-Edwards J.W., Goldman M.B., Willett W.C., et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 171 1 (1994) 171-177
10. Hartz A.J., Barboriak P.N., Wong A., Katayama K.P., and Rimm A.A. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes 3 1 (1979) 57-73
11. Cui Y., Whiteman M.K., Flaws J.A., Langenberg P., Tkaczuk K.H., and Bush T.L. Body mass and stage of breast cancer at diagnosis. Int J Cancer 98 2 (2002) 279-283
12. Garmendia M.L., Pereira A., Alvarado M.E., and Atalah E. Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol 17 6 (2007) 403-409
13. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrinol Rev 21 6 (2000) 697-738
14. Douchi T., Kuwahata R., Yamamoto S., Oki T., Yamasaki H., and Nagata Y. Relationship of upper body obesity to menstrual disorders. Acta Obstet Gynecol Scand 81 2 (2002) 147-150
15. Kaaks R., Berrino F., Key T., et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97 10 (2005) 755-765
16. Muti P., Stanulla M., Micheli A., et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112 2 (2004) 312-318
17. Eliassen A.H., Missmer S.A., Tworoger S.S., et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98 19 (2006) 1406-1415
18. Sonnenschein E., Toniolo P., Terry M.B., et al. Body fat distribution and obesity in pre-and postmenopausal breast cancer. Int J Epidemiol 28 6 (1999) 1026-1031
19. Adams-Campbell L.L., Nwankwo M., Ukoli F., Omene J., Haile G.T., and Kuller L.H. Body fat distribution patterns and blood pressure in black and white women. J Natl Med Assoc 82 8 (1990) 573-576
20. Seidell J.C., Cigolini M., Charzewska J., Ellsinger B.M., and Contaldo F. Regional obesity and serum lipids in European women born in 1948. A multicenter study. Acta Med Scand 723 Suppl. (1988) 189-197
21. Huang Z., Willett W.C., Colditz G.A., et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 150 12 (1999) 1316-1324
22. Friedenreich C.M. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 10 1 (2001) 15-32
23. Schapira D.V., Kumar N.B., Lyman G.H., and Cox C.E. Abdominal obesity and breast cancer risk. Ann Intern Med 112 3 (1990) 182-186
24. McCarty M.F. A paradox resolved: the postprandial model of insulin resistance explains why gynoid adiposity appears to be protective. Med Hypotheses 61 2 (2003) 173-176
25. Snijder M.B., Dekker J.M., Visser M., et al. Larger thigh and hip circumferences are associated with better glucose tolerance: the Hoorn study. Obes Res 11 1 (2003) 104-111
26. Connolly B.S., Barnett C., Vogt K.N., Li T., Stone J., and Boyd N.F. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr Cancer 44 2 (2002) 127-138
27. Larsson S.C., Mantzoros C.S., and Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121 4 (2007) 856-862
28. Lawlor D.A., Smith G.D., and Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15 3 (2004) 267-275
29. Schairer C., Hill D., Sturgeon S.R., et al. Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women. Int J Cancer 108 5 (2004) 773-779
30. Verheus M., Peeters P.H., Rinaldi S., et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 119 3 (2006) 659-667
31. Sieri S., Pala V., Brighenti F., et al. Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study. Am J Clin Nutr 86 4 (2007) 1160-1166
32. Micheli A., Muti P., Secreto G., et al. Markers of insulin resistance and sex steroid hormone activity in relation to breast cancer risk: a prospective analysis of abdominal adiposity, sebum production, and hirsutism. Cancer Causes Control 11 8 (2000) 721-730
33. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
34. Tworoger S.S., Eliassen A.H., Kelesidis T., et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab 92 4 (2007) 1510-1516
35. Miyoshi Y., Funahashi T., Kihara S., et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 9 15 (2003) 5699-5704
36. Chen D.C., Chung Y.F., Yeh Y.T., et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett 237 1 (2006) 109-114
37. Mantzoros C., Petridou E., Dessypris N., et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 89 3 (2004) 1102-1107
38. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
39. Hamelers I.H., and Steenbergh P.H. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr Relat Cancer 10 2 (2003) 331-345
40. Cascio S., Bartella V., Garofalo C., Russo A., Giordano A., and Surmacz E. Insulin-like growth factor 1 differentially regulates estrogen receptor-dependent transcription at estrogen response element and AP-1 sites in breast cancer cells. J Biol Chem 282 6 (2007) 3498-3506
41. Chong Y.M., Williams S.L., Elkak A., Sharma A.K., and Mokbel K. Insulin-like growth factor 1 (IGF-1) and its receptor mRNA levels in breast cancer and adjacent non-neoplastic tissue. Anticancer Res 26 1A (2006) 167-173
42. Baik I., Devito W.J., Ballen K., et al. Association of fetal hormone levels with stem cell potential: evidence for early life roots of human cancer. Cancer Res 65 1 (2005) 358-363
43. Savarese T.M., Strohsnitter W.C., Low H.P., et al. Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res 9 3 (2007) R29
44. Park S.K., Kang D., McGlynn K.A., Garcia-Closas M., Kim Y., Yoo K.Y., et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res. 10 1 (2008) R8
45. Schernhammer E.S., Holly J.M., Hunter D.J., et al. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in the Nurses Health Study II. Endocr Relat Cancer 13 (2006) 583-592
46. Salpeter S.R., Walsh J.M., Ormiston T.M., Greyber E., Buckley N.S., and Salpeter E.E. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Review. Diabetes Obes Metab 8 5 (2006) 538-554
47. Michels K.B., and Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer 119 9 (2006) 2007-2025
48. Campagnoli C., Abbà C., Ambroggio S., and Peris C. Differential effects of progestins on the circulating IGF-I system. Review. Maturitas 46 Suppl. 1 (2003) S39-S44
49. Krebs E.E., Taylor B.C., Cauley J.A., Stone K.L., Bowman P.J., and Ensrud K.E. Measures of adiposity and risk of breast cancer in older postmenopausal women. J Am Geriatr Soc 54 1 (2006) 63-69
50. Eliassen A.H., Colditz G.A., Rosner B., Willett W.C., and Hankinson S.E. Adult weight change and risk of postmenopausal breast cancer. JAMA 296 2 (2006) 193-201
51. Tworoger S.S., Eliassen A.H., Missmer S.A., et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomarkers Prev 15 12 (2006) 2494-2501
52. Harvie M., Howell A., Vierkant R.A., et al. Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study. Cancer Epidemiol Biomarkers Prev 14 3 (2005) 656-661
53. Eng S.M., Gammon M.D., Terry M.B., et al. Body size changes in relation to postmenopausal breast cancer among women onLong Island, New York. Am J Epidemiol 162 3 (2005) 229-237
54. Morimoto L.M., White E., Chen Z., et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 13 8 (2002) 741-751
55. Furberg A.S., Veierød M.B., Wilsgaard T., Bernstein L., and Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 96 15 (2004) 1152-1160